The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2005
Emotionally labile, depressed participants with multiple sclerosis treated with escitalopram will have a greater reduction in emotional lability scores and in their psychological distress scores than those who are randomized to receive placebo.
Epistemonikos ID: 134168f62e56e640ff2ec3c3f827aa49aabe387c
First added on: Mar 31, 2022